Evidence map›Paper›PMID 29401167›Full record

ArticlePancreas2018

The Association of Recently Diagnosed Diabetes and Long-term Diabetes With Survival in Pancreatic Cancer Patients: A Pooled Analysis.

Christie Y Jeon, Donghui Li, Sean Cleary, Rachael Stolzenberg-Solomon, Cristina Bosetti, Carlo La Vecchia, Miquel Porta, Adetunji T Toriola, Rayjean J Hung, Robert C Kurtz and 1 more

Abstract readMulticenter Study
In one paragraph

Article in Pancreas, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Diabetes and pancreatic cancer risk in a multiracial cohort.Diabetic medicine : a journal of the British Diabetic Association · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 4 countries.

Christie Y Jeon
Donghui Li
Sean Cleary
Rachael Stolzenberg-Solomon
Cristina Bosetti
Carlo La Vecchia
Miquel Porta
Adetunji T Toriola
Rayjean J Hung
Robert C Kurtz
Sara H Olson
Mayo Clinic in Arizona · USNational Cancer Institute · USCedars-Sinai Medical Center · USHospital Del Mar · ESIstituti di Ricovero e Cura a Carattere Scientifico · ITLunenfeld-Tanenbaum Research Institute · CAUniversity of Milan · ITUniversity of Toronto · CAWashington University in St. Louis · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Whole Genome Scan in the Pancreatic Cancer Cohort Consortium (PanScan)ZIACP010193 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI STOLZENBERG-SOLOMON, RACHAEL · 2009 to 2025
$9.5M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

objectivesIt is unclear whether long-standing diabetes or new-onset pancreatogenic diabetes contributes to poor prognosis in patients with pancreatic ductal adenocarcinoma (PDAC).

methodsWe investigated the influence of diabetes diagnosed shortly before PDAC and long-term diabetes on overall survival in 2792 PDAC patients who had participated in 3 PDAC case-control studies in the Pancreatic Cancer Case-Control Consortium. There were 300 patients with long-term diabetes of more than 3 years' duration (11%) and 418 patients with recently diagnosed diabetes of 3-year duration or less (15%). We performed Cox regression to determine the association of long-term diabetes and recently diagnosed diabetes with overall survival, adjusting for study site, age, sex, race, stage of disease, surgery, chemotherapy, smoking history, and body mass index at diagnosis.

resultsIn the overall population, neither long-term diabetes (hazard ratio [HR], 1.10; 95% confidence interval [CI], 0.97-1.26) nor recently diagnosed diabetes (HR, 1.06; 95% CI, 0.94-1.18) was associated with shorter survival. When stratified by stage of disease, long-term diabetes was associated with 42% increase in rate of death in persons with resectable PDAC (HR, 1.42; 95% CI, 1.13-1.78), whereas it was not associated with survival in PDAC patients with more advanced disease.

conclusionLong-term diabetes was associated with increased rate of death in patients with resectable PDAC.

Indexed as

AgedCarcinoma, Pancreatic DuctalDiabetes MellitusFemaleHumansKaplan-Meier EstimateMaleMiddle AgedOutcome Assessment, Health CarePancreasPancreatic NeoplasmsPrognosisProportional Hazards ModelsRisk FactorsTime Factors

Identifiers

PMID29401167
PMCPMC5807116
OpenAlexW2790015332

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.